Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter
Author:
Affiliation:
1. Department of Diabetes and Endocrinology; City Hospital; Birmingham UK
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12703/fullpdf
Reference10 articles.
1. Pioglitazone: are rumours of its death exaggerated?;Gale;Diabet Med,2015
2. Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit;Ryder;Diabet Med,2015
3. Pioglitazone - reports of its death are greatly exaggerated* - it is alive and ready to resume saving lives;Ryder;Diabet Med,2015
4. Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis;Turner;Br J Clin Pharmacol,2014
5. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis;Colmers;Can Med Assoc J,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pioglitazone, Bladder Cancer, and the Presumption of Innocence;Current Drug Safety;2022-11
2. Pioglitazone: inexpensive; very effective at reducing HbA 1c ; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit;Diabetic Medicine;2019-07
3. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis;Cancer Medicine;2018-02-24
4. Kardiale Effekte aktueller Antidiabetika;CardioVasc;2016-06
5. Wie hoch ist der Patientennutzen wirklich?;MMW - Fortschritte der Medizin;2016-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3